HemaSphere (Jun 2022)

P966: DARATUMUMAB, CARFILZOMIB, POMALIDOMIDE AND ELOTUZUMAB FOR THE TREATMENT OF POEMS SYNDROME- THE MAYO CLINIC EXPERIENCE

  • I. Vaxman,
  • S. Kumar,
  • F. buadi,
  • M. Lacy,
  • D. Dingli,
  • A. Fonder,
  • M. Hobbs,
  • S. Hayman,
  • L. Y. hwa,
  • T. Kouralis,
  • R. Warsame,
  • E. Muchtar,
  • L. Nelson,
  • P. Kapoor,
  • M. Grogan,
  • R. Go,
  • W. Gonsalves,
  • M. Siddiqi,
  • K. Robert,
  • V. Rajkumar,
  • M. Gertz,
  • A. Dispenzieri

DOI
https://doi.org/10.1097/01.HS9.0000846732.06415.be
Journal volume & issue
Vol. 6
pp. 856 – 857

Abstract

Read online

No abstracts available.